Editas Medicine, Inc.
CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING BETA HEMOGLOBINOPATHIES
Last updated:
Abstract:
CRISPR/CAS-related compositions and methods for treatment of beta hemoglobinopathies are disclosed.
Status:
Application
Type:
Utility
Filling date:
14 Mar 2017
Issue date:
13 Aug 2020